Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
Condition(s):Brain and Central Nervous System Tumors; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:February 20, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Brain and Central Nervous System Tumors; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:February 20, 2014Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 26, 2013Completed
Condition(s):Brain Tumor; Central Nervous System Tumors; Cachexia; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:February 3, 2014Completed
Condition(s):Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:December 23, 2016Terminated
Condition(s):Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:April 29, 2015Completed
Condition(s):Brain TumorsLast Updated:April 19, 2022Active, not recruiting
Condition(s):Brain and Central Nervous System Tumors; Gastrointestinal Stromal Tumor; SarcomaLast Updated:December 28, 2010Completed
Condition(s):Cognitive Impairment; Cognitive Decline; Radiotherapy Side Effect; Radiotherapy; Complications; Brain Tumor; Memory Impairment; Late Effect of RadiationLast Updated:September 22, 2023Not yet recruiting
Condition(s):MedulloblastomaLast Updated:June 15, 2023Active, not recruiting
Condition(s):Brain and Central Nervous System TumorsLast Updated:January 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.